BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6648868)

  • 1. Effect of aerosol fenoterol on the severity of bronchial hyperreactivity in patients with asthma.
    Salome CM; Schoeffel RE; Yan K; Woolcock AJ
    Thorax; 1983 Nov; 38(11):854-8. PubMed ID: 6648868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of aerosol and oral fenoterol on histamine and methacholine challenge in asthmatic subjects.
    Salome CM; Schoeffel RE; Woolcock AJ
    Thorax; 1981 Aug; 36(8):580-4. PubMed ID: 7031973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect throughout the day of inhaled fenoterol on the bronchial responsiveness to histamine in asthmatic patients.
    Carpentiere G; Castello F; Marino S
    Respiration; 1987; 52(1):16-21. PubMed ID: 3659581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regular inhaled beta agonist in asthma: effects on exacerbations and lung function.
    Taylor DR; Sears MR; Herbison GP; Flannery EM; Print CG; Lake DC; Yates DM; Lucas MK; Li Q
    Thorax; 1993 Feb; 48(2):134-8. PubMed ID: 8493626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of SCH 1000 on bronchial hyperreactivity compared to that of fenoterol].
    Dakhil J; Clauzel AM; Michel FB
    Respiration; 1984; 46(4):370-8. PubMed ID: 6240749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of SCH 1000 and fenoterol after histamine-induced bronchoconstriction in asymptomatic asthmatics.
    Scano G; Stendardi L; Gigliotti F; Esposito-Iacenna V; Sergysels R; Bracamente M; De Coster A
    Int J Clin Pharmacol Ther Toxicol; 1984 Feb; 22(2):81-5. PubMed ID: 6230326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of an inhaled neutral endopeptidase inhibitor, phosphoramidon, on baseline airway calibre and bronchial responsiveness to bradykinin in asthma.
    Crimi N; Polosa R; Pulvirenti G; Magrì S; Santonocito G; Prosperini G; Mastruzzo C; Mistretta A
    Thorax; 1995 May; 50(5):505-10. PubMed ID: 7597662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histamine-induced bronchial response after administration of placebo, salbutamol and a combination of a beta-2-adrenergic drug (fenoterol) with an anticholinergic agent (ipratropium bromide) in asymptomatic asthma patients.
    Fontana G; Mugnai M; Cresci F; Panuccio P
    Respiration; 1986; 50 Suppl 2():201-5. PubMed ID: 2951806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of ipratropium and fenoterol on methacholine-histamine-induced bronchoconstriction.
    Bandouvakis J; Cartier A; Roberts R; Ryan G; Hargreave FE
    Br J Dis Chest; 1981 Jul; 75(3):295-305. PubMed ID: 6457620
    [No Abstract]   [Full Text] [Related]  

  • 10. Aerosol administration of fenoterol hydrobromide (Th 1165a) in subjects with reversible obstructive airway disease.
    Pennock BE; Rogers RM; Ryan BR; Ayers LN
    Chest; 1977 Dec; 72(6):731-6. PubMed ID: 336306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment of exercise-induced asthma by fenoterol delivered as inhalation powder and pressurized aerosol.
    Bundgaard A; Schmidt A
    Ann Allergy; 1982 Jan; 48(1):36-9. PubMed ID: 7055343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchial responsiveness during regular fenoterol therapy: four months prospective study.
    Town GI; O'Donnell TV; Purdie G
    N Z Med J; 1991 Jan; 104(904):3-5. PubMed ID: 2008260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind crossover study on the protective effect of fenoterol--administered by pressurized aerosol and in powder form--in allergen-induced asthma.
    D'Amato G; Schiano M; Cocco G; Melillo G
    Respiration; 1984; 45(3):276-80. PubMed ID: 6379789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of fenoterol aerosol in asthma.
    Chervinsky P
    Ann Allergy; 1977 Sep; 39(3):179-83. PubMed ID: 900585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of prior treatment with salmeterol and formoterol on airway and systemic beta 2 responses to fenoterol.
    Grove A; Lipworth BJ
    Thorax; 1996 Jun; 51(6):585-9. PubMed ID: 8693438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenoterol dose-response study in children with asthma.
    Feldman CH; Sher TH; Hutchinson VE; Feldman BR; Davis WJ
    J Allergy Clin Immunol; 1984 Mar; 73(3):356-62. PubMed ID: 6699315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-response characteristics of nebulized fenoterol in asthmatic children.
    Reilly PA; Yahav J; Mindorff C; Kazim F; Levison H
    J Pediatr; 1983 Jul; 103(1):121-6. PubMed ID: 6864377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dose-response study on fenoterol (Berotec) solution by inhalation in asthmatic children.
    Blackhall MI; Macartney B; O'Donnell SR
    Dev Pharmacol Ther; 1983; 6(6):374-80. PubMed ID: 6357677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dose fenoterol aerosol protects against histamine-induced bronchoconstriction in mild asthmatics: a dose response study.
    Magnussen H; Rabe KF
    Clin Exp Allergy; 1992 Jul; 22(7):690-3. PubMed ID: 1504891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind trial with standard doses of fenoterol and salbutamol in asthmatic children.
    Graff-Lonnevig V
    Acta Allergol; 1976 Dec; 31(6):463-70. PubMed ID: 797215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.